Jul-07-20 Initiated
Needham
Buy
$40
Jul-07-20 Initiated
Cantor Fitzgerald
Overweight
$55
Jul-07-20 Initiated
BofA Securities
Buy
$37
Jan-06-21 08:15AM
Dec-22-20 08:00AM
Dec-10-20 06:34PM
Nov-24-20 04:05PM
Nov-12-20 04:15PM
Nov-10-20 04:41PM
Sep-23-20 07:00AM
Sep-14-20 02:27PM
Sep-09-20 05:28PM
Aug-14-20 03:01PM Investor's Business Daily +8.71%
Aug-12-20 04:59PM
04:10PM
Jun-16-20 04:05PM
Jun-12-20 11:24AM
06:18AM
01:06AM
Jun-03-20 08:30AM
May-21-20 08:30AM
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging strains causing significant invasive pneumococcal disease and antibiotic resistance; VAX-A1, a conjugate vaccine candidate for protection against subtypes of Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting porphyromonas gingivalis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was founded in 2013 and is headquartered in Foster City, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fairman Jeff VP, Research Feb 26 Option Exercise 0.04 4,750 190 6,158 Mar 02 05:37 PM Fairman Jeff VP, Research Feb 26 Sale 23.93 4,750 113,663 1,408 Mar 02 05:37 PM PICKERING GRANT President & CEO Feb 22 Option Exercise 1.79 15,000 26,850 593,691 Feb 24 04:23 PM Wassil Jim Chief Operating Officer Feb 22 Option Exercise 2.42 3,000 7,260 19,381 Feb 24 04:25 PM Wassil Jim Chief Operating Officer Feb 22 Sale 26.77 3,000 80,299 16,381 Feb 24 04:25 PM PICKERING GRANT President & CEO Feb 22 Sale 26.47 15,000 397,036 578,691 Feb 24 04:23 PM Wright-Mitchell Jane General Counsel Feb 16 Option Exercise 2.03 2,500 5,075 4,062 Feb 17 04:55 PM Wright-Mitchell Jane General Counsel Feb 16 Sale 26.95 2,500 67,375 1,562 Feb 17 04:55 PM Sauer Paul SVP Process Dev, Manufacturing Feb 11 Option Exercise 1.79 2,500 4,475 80,399 Feb 16 07:46 PM Sauer Paul SVP Process Dev, Manufacturing Feb 11 Sale 26.65 2,500 66,624 77,899 Feb 16 07:46 PM Hopfner Robert Lorne Director Feb 10 Sale 26.53 78,158 2,073,658 1,405,418 Feb 10 07:22 PM Hopfner Robert Lorne Director Feb 09 Sale 28.19 220,744 6,223,692 1,483,576 Feb 10 07:22 PM Hopfner Robert Lorne Director Feb 08 Sale 25.79 79,796 2,058,117 1,704,320 Feb 10 07:22 PM Hopfner Robert Lorne Director Feb 03 Sale 25.06 2,768 69,366 1,784,116 Feb 04 08:51 PM Hopfner Robert Lorne Director Feb 02 Sale 25.13 14,234 357,700 1,786,884 Feb 04 08:51 PM Hopfner Robert Lorne Director Jan 28 Sale 25.07 2,000 50,140 1,801,118 Feb 02 12:17 PM Hopfner Robert Lorne Director Jan 27 Sale 25.30 2,140 54,142 1,803,118 Jan 27 06:02 PM Fairman Jeff VP, Research Jan 26 Option Exercise 0.04 4,750 190 6,158 Jan 28 04:36 PM Fairman Jeff VP, Research Jan 26 Sale 25.27 4,750 120,014 1,408 Jan 28 04:36 PM Hopfner Robert Lorne Director Jan 26 Sale 25.30 18,142 458,958 1,805,258 Jan 27 06:02 PM Hopfner Robert Lorne Director Jan 25 Sale 25.81 34,972 902,745 1,823,400 Jan 27 06:02 PM Hopfner Robert Lorne Director Jan 22 Sale 25.16 11,383 286,396 1,858,372 Jan 22 06:10 PM Hopfner Robert Lorne Director Jan 21 Sale 25.11 100 2,511 1,869,755 Jan 22 06:10 PM Wassil Jim Chief Operating Officer Jan 20 Option Exercise 2.42 3,000 7,260 19,381 Jan 21 07:12 PM Wassil Jim Chief Operating Officer Jan 20 Sale 25.50 3,000 76,500 16,381 Jan 21 07:12 PM Hopfner Robert Lorne Director Jan 20 Sale 25.35 19,046 482,816 1,869,855 Jan 22 06:10 PM PICKERING GRANT President & CEO Jan 19 Option Exercise 1.79 15,000 26,850 593,691 Jan 21 06:58 PM PICKERING GRANT President & CEO Jan 19 Sale 25.10 15,000 376,498 578,691 Jan 21 06:58 PM Hopfner Robert Lorne Director Jan 19 Sale 25.62 49,516 1,268,634 1,888,901 Jan 19 09:07 PM Wright-Mitchell Jane General Counsel Jan 15 Option Exercise 2.03 2,500 5,075 4,062 Jan 19 06:29 PM Hopfner Robert Lorne Director Jan 15 Sale 25.78 26,677 687,846 1,938,417 Jan 19 09:07 PM Wright-Mitchell Jane General Counsel Jan 15 Sale 26.00 2,500 65,000 1,562 Jan 19 06:29 PM Hopfner Robert Lorne Director Jan 14 Sale 25.88 14,918 386,078 1,965,094 Jan 19 09:07 PM Hopfner Robert Lorne Director Jan 13 Sale 25.95 29,110 755,313 1,980,012 Jan 13 08:39 PM Hopfner Robert Lorne Director Jan 12 Sale 26.38 18,567 489,871 2,009,122 Jan 13 08:39 PM Sauer Paul SVP Process Dev, Manufacturing Jan 11 Option Exercise 1.79 2,500 4,475 80,399 Jan 12 09:43 PM Hopfner Robert Lorne Director Jan 11 Sale 26.45 49,666 1,313,764 2,027,689 Jan 13 08:39 PM Sauer Paul SVP Process Dev, Manufacturing Jan 11 Sale 26.21 2,500 65,527 77,899 Jan 12 09:43 PM Hopfner Robert Lorne Director Jan 08 Sale 26.58 40,612 1,079,549 2,077,355 Jan 08 05:17 PM Hopfner Robert Lorne Director Jan 07 Sale 28.27 47,580 1,344,887 2,117,967 Jan 08 05:17 PM Hopfner Robert Lorne Director Jan 06 Sale 29.53 57,420 1,695,841 2,165,547 Jan 08 05:17 PM Fairman Jeff VP, Research Dec 29 Option Exercise 1.79 740 1,325 1,408 Dec 30 08:26 PM PICKERING GRANT President & CEO Dec 28 Option Exercise 1.79 5,500 9,845 578,691 Dec 29 06:01 PM PICKERING GRANT President & CEO Dec 21 Option Exercise 1.79 15,000 26,850 588,191 Dec 22 08:44 PM PICKERING GRANT President & CEO Dec 21 Sale 28.88 15,000 433,141 573,191 Dec 22 08:44 PM TPG Group Holdings (SBS) Advis Former 10% Owner Dec 15 Sale 32.50 81,979 2,664,691 5,074,574 Dec 17 07:13 PM RA CAPITAL MANAGEMENT, L.P. 10% Owner Oct 08 Sale 50.69 167,661 8,498,065 5,001,593 Oct 09 04:22 PM RA CAPITAL MANAGEMENT, L.P. 10% Owner Oct 07 Sale 50.95 98,597 5,023,527 5,169,254 Oct 09 04:22 PM RA CAPITAL MANAGEMENT, L.P. 10% Owner Sep 30 Sale 50.27 124,656 6,265,871 5,283,818 Oct 01 05:25 PM RA CAPITAL MANAGEMENT, L.P. 10% Owner Sep 29 Sale 52.08 80,707 4,202,987 5,408,474 Oct 01 05:25 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite